Enhanced bone formation in lipodystrophic PPARγhyp/hyp mice relocates haematopoiesis to the spleen

The peroxisome proliferator‐activated receptor gamma (PPARγ) controls adipogenesis and metabolism. We demonstrate here that the absence of PPARγ in fat has potent osteogenic activities, which affect haematopoiesis. The congenital absence of PPARγ in fat of lipodystrophic PPARγ hyp/hyp mice, strongly...

Full description

Saved in:
Bibliographic Details
Published inEMBO reports Vol. 5; no. 10; pp. 1007 - 1012
Main Authors Cock, Terrie-Anne, Back, Jonathan, Elefteriou, Florent, Karsenty, Gérard, Kastner, Philippe, Chan, Susan, Auwerx, Johan
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.10.2004
Nature Publishing Group UK
Subjects
Online AccessGet full text
ISSN1469-221X
1469-3178
DOI10.1038/sj.embor.7400254

Cover

More Information
Summary:The peroxisome proliferator‐activated receptor gamma (PPARγ) controls adipogenesis and metabolism. We demonstrate here that the absence of PPARγ in fat has potent osteogenic activities, which affect haematopoiesis. The congenital absence of PPARγ in fat of lipodystrophic PPARγ hyp/hyp mice, strongly enhanced bone mass and consequentially reduced the bone‐marrow cavity. Consistent with this, PPARγ hyp/hyp mice had a significant decrease in bone marrow cellularity and resorted to extramedullary haematopoiesis in the spleen to maintain haematopoiesis. Our data indicate that antagonizing PPARγ activity in fat could be an effective way to combat osteoporosis and suggest that haematopoietic function should be scrutinized in lipodystrophic subjects.
Bibliography:ark:/67375/WNG-58QFF6TK-Z
ArticleID:EMBR7400254
istex:7D54F85B4486167944AE708182E009FC1F78767F
These authors contributed equally to this work
ISSN:1469-221X
1469-3178
DOI:10.1038/sj.embor.7400254